Response to Tony Badrick regarding "Letter to the Editor regarding the article by Wayne J. Dimech et al. Time to address quality control processes applied to antibody testing for infectious diseases. Clin Chem Lab Med 2023; 61(2):205-212 by"
Clin Chem Lab Med
.
2023 Mar 6;61(8):e137-e139.
doi: 10.1515/cclm-2023-0178.
Print 2023 Jul 26.
Authors
Wayne J Dimech
1
,
Giuseppe A Vincini
2
,
Mario Plebani
3
,
Giuseppe Lippi
4
,
James H Nichols
5
,
Oswald Sonntag
6
Affiliations
1
Scientific and Business Relations Manager, National Serology Reference Laboratory, Fitzroy, Australia.
2
National Serology Reference Laboratory, Melbourne, Australia.
3
University-Hospital of Padova, Padova, Italy.
4
Department of Clinical Biochemistry, University of Verona, Verona, Italy.
5
Vanderbilt University Medical Center, Nashville, TN, USA.
6
Scientific Consultant, Eichenau, Germany.
PMID:
36872632
DOI:
10.1515/cclm-2023-0178
No abstract available
Keywords:
QConnect; infectious diseases; quality control; serology.
Publication types
Letter
Comment
MeSH terms
Communicable Diseases* / diagnosis
Humans
Immunologic Tests
Quality Control